Suppr超能文献

哺乳动物不育 20 样激酶 1 和 2 及 Yes 相关蛋白 1 蛋白在三阴性乳腺癌中的表达及其临床病理意义。

Expression of mammalian sterile 20-like kinase 1 and 2 and Yes-associated protein 1 proteins in triple-negative breast cancer and the clinicopathological significance.

机构信息

Department of Pathology, Suzhou Hospital of Anhui Medical University (Suzhou Municipal Hospital of Anhui Province), Suzhou, Anhui, China.

Department of Pathology, Bengbu Medical College, Bengbu, Anhui, China.

出版信息

Medicine (Baltimore). 2021 Aug 27;100(34):e27032. doi: 10.1097/MD.0000000000027032.

Abstract

BACKGROUND AND AIM

Mammalian sterile 20-like kinase 1 and 2 (MST1/2) and Yes-associated protein 1 (YAP1) are the core molecules of the Hippo signaling pathway, which have been found to be unbalanced in the occurrence of tumors and promote the development of the lesions. The present study aimed to investigate the expression of MST1/2 and YAP1 proteins in triple-negative breast cancer (TNBC) and their clinicopathological significance.

METHODS

Immunohistochemistry was used to detect the expression level of protein in tissues. According to the percentage of positive cells and staining intensity, the expression intensity of MST1/2 and YAP1 proteins in the tissue samples was scored, and the correlation between MST1/2 and the clinicopathological features of TNBC were discussed.

RESULTS

The expression of MST1/2 and YAP1 was associated with histological grade, metastasis, lymph node metastasis stage, and tumor node metastasis stage. The overexpression of YAP1 predicted a poor prognosis in terms of overall survival and disease-free survival time. The MST1/2 expression was associated with improved overall survival and disease free survival of the patients.

CONCLUSION

MST1/2 and YAP1 may be used as prognostic indicators to evaluate the recurrence of TNBC and might become one of the new targets for breast cancer treatment.

摘要

背景与目的

哺乳动物致死性 20 样激酶 1 和 2(MST1/2)和 Yes 相关蛋白 1(YAP1)是 Hippo 信号通路的核心分子,在肿瘤的发生中发现它们失衡,并促进病变的发展。本研究旨在探讨 MST1/2 和 YAP1 蛋白在三阴性乳腺癌(TNBC)中的表达及其与临床病理特征的关系。

方法

采用免疫组织化学方法检测组织中蛋白的表达水平。根据阳性细胞的百分比和染色强度对 MST1/2 和 YAP1 蛋白在组织样本中的表达强度进行评分,并探讨 MST1/2 与 TNBC 临床病理特征的相关性。

结果

MST1/2 和 YAP1 的表达与组织学分级、转移、淋巴结转移分期和肿瘤淋巴结转移分期有关。YAP1 的过表达与总生存和无病生存时间的预后不良相关。MST1/2 的表达与患者的总生存和无病生存时间改善有关。

结论

MST1/2 和 YAP1 可作为预测 TNBC 复发的预后指标,可能成为乳腺癌治疗的新靶点之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6430/8389968/a7e87cd88aa5/medi-100-e27032-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验